Shopping Cart
- Remove All
- Your shopping cart is currently empty
RF9 acetate is an effective and selective antagonist of Neuropeptide FF receptor with Ki values of 58 and 75 nM for hNPFF1R and hNPFF2R, respectively.
Pack Size | Price | Availability | Quantity |
---|---|---|---|
1 mg | $98 | In Stock | |
5 mg | $212 | In Stock | |
10 mg | $318 | In Stock | |
25 mg | $573 | In Stock | |
50 mg | $819 | In Stock | |
100 mg | $1,130 | In Stock | |
1 mL x 10 mM (in DMSO) | $283 | In Stock |
Description | RF9 acetate is an effective and selective antagonist of Neuropeptide FF receptor with Ki values of 58 and 75 nM for hNPFF1R and hNPFF2R, respectively. |
Targets&IC50 | NPFF2 (human):75 nM (Ki), NPFF1 (human):58 nM (Ki) |
In vitro | In Neuro 2A cells, Pretrement of RF9 acetate (10 μM) completely blocks NPFF induced neurite outgrowth[2]. |
In vivo | RF9 acetate (10 μg) infused alone does not result in a significant alteration of MAP or heart rate. Conversely, MAP and heart rate increases evoked by NPFF are significantly blocked When RF9 acetate is applied in conjunction with NPFF. RF9 acetate (0.1 mg/kg, s.c. min before 0.3 mg/kg heroin or saline on basal nociceptive threshold) with heroin coadministration prevents heroin-induced delayed hyperalgesia and tolerance[2]. |
Molecular Weight | 542.67 |
Formula | C28H42N6O5 |
Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. | |||||||||||||||||||||||||||||||||||
Solubility Information | DMSO: 55 mg/mL (101.35 mM) | |||||||||||||||||||||||||||||||||||
Solution Preparation Table | ||||||||||||||||||||||||||||||||||||
DMSO
|
Copyright © 2015-2024 TargetMol Chemicals Inc. All Rights Reserved.